Switzerland - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Enterprise Financing Schemes
Since 2014, Switzerland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Enterprise Financing Schemes decreased by 27.5% year on year. In 2019, the country was ranked number 2 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Enterprise Financing Schemes at €0.04 Per Capita. Germany topped the ranking with €1.09 Per Capita in 2019, +2.8% versus 2018. Germany witnessed the best average annual growth at +3.2% per year, while Switzerland recorded the worst performance at -27.5% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 0.04 |
| 2018 | 0.03 |
| 2017 | 0.02 |
| 2016 | 0.19 |
| 2015 | 0.02 |
Download all data from 2010 to 2019
How does Switzerland rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Enterprise Financing Schemes?
| # | 2 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
1.09 | 2019 | +2.8 % | +3.2 % | View data |
| 2 |
#2
Switzerland
|
0.04 | 2019 | +33.3 % | -27.5 % | View data |